The US government's transformation of $11.1 billion in subsidies into a 9.9% equity stake in Intel via the Chips and Science Act has stirred apprehension among investors over potential government meddling in private enterprises. While the arrangement does not accord the government a seat on Intel's board of directors, it does empower the government to determine its voting stance independently on various matters. This could potentially blur the boundaries between the public and private sectors, giving rise to risks such as regulatory complications, insider trading, and conflicts of interest. While such practices are more prevalent in Europe and Asia, they are uncommon in the US, particularly for financially robust companies. Some analysts have warned that if the government persists in acquiring equity stakes in other firms, it may indicate a shift towards 'state capitalism' in the US.